Erik Sparve

Erik Sparve currently serves as the Global Product Safety Science Lead at Sobi - Swedish Orphan Biovitrum AB (publ) since June 2018, focusing on post-marketing activities, clinical studies, safety surveillance, and regulatory interactions across various global markets. Previous experience includes roles as a Senior Physician in Clinical Pharmacology at Unilabs and a Resident/Senior Physician in Psychiatry at Karolinska Universitetssjukhuset. Erik's early career involved work as a Clinical Pharmacology Physician at AstraZeneca, with responsibilities including early-phase development in CNS indications. Erik holds multiple degrees in medicine and pharmacology, including a specialist certification in Psychiatry and Clinical Pharmacology, and continues to expand qualifications with ongoing training in clinical pharmacology.